Outcomes of the treatment with glecaprevir/pibrentasvir following heart transplantation utilizing hepatitis C viremic donors | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Outcomes of the treatment with glecaprevir/pibrentasvir following heart transplantation utilizing hepatitis C viremic donors

Reyentovich A, Gidea CG, Smith D, et al. Outcomes of the treatment with glecaprevir/pibrentasvir following heart transplantation utilizing hepatitis C viremic donors. Clin Transplant. 2020;34(9):e13989.

Publication Type:

Journal Article

Authors:

Reyentovich, A; Gidea, CG; Smith, D; et, al

Source:

Clin Transplant, Volume 34, Issue 9, p.e13989 (2020)

Cited On:

Treatment of HCV-Uninfected Transplant Recipients Receiving Organs From HCV-Viremic Donors

Export Citation:

RIS Format

Top